Click to enlarge. Source: Express Scripts. H/t: Michael Ramlet. (There will not be a TIE chart of the day every day.)
Authors
-
Recent posts
- Fluoridation
- How to debate a wing nut
- Chart of the day: Cognitive ability and enrollment into public programs
- Cutting the budget for inspections of compounding pharmacies
- Sound Medicine: Why are employers offering health care incentives?
- “Body Ritual among the Nacirema”
- A conversation with Keith Humphreys on health reform, mental health, and substance abuse treatment
- Micro and macro totems
- Bias, validity, and terminology
- The sequester is hurting mental health research
Archives
For speaking inquiries
Aaron’s stuff
Austin’s stuff
-
Chart of the day: brand vs. generic drug price growth
November 29, 2012 at 12:00 pm
Austin FraktWrite a comment
Follow the blog
TIE Books
Tag cloud
AcademyHealth accountable care organizations Affordable Care Act announcement antitrust blogging books comic competitive bidding costs cost shifting deficit employer-sponsored health insurance health care costs health insurance health insurance mandates health reform hospital readmissions hospitals instrumental variables insurance exchange market power Massachusetts Medicaid Medicare mortality obesity On The Record physicians politics PPACA premiums premium support prescription drugs prostate cancer quality reading list reflex RWJF single payer spending substance use tax uninsured xkcd
Loading
by steve on November 29th, 2012 at 21:40
And this is w/o any new blockbusters coming out for the most part.
Steve
by David J. Littleboy on November 30th, 2012 at 03:23
FWIW, and as you might expect, Japan is very aggressive about switching to generics as soon as they are available. And is very upfront about telling the patient; the pharmacy that fills my prescription is appologetic about charging me (my 30%; insurance covers the other 70%) for non-generics, explaining that they’ve switched to a generic of this but that a a generic version of that isn’t out yet. (I mention this because I understand that there’s some fine print in Medicare that prevents a switch to generics in some cases.)
by Scott Supak on December 4th, 2012 at 17:19
I just sent this to Dean Baker. I hope his head doesn’t explode.
The fact that the people who missed the largest asset bubble in history are now paid to tell us that extended patent protections are a good thing is a tragedy, It’s certainly not “free markets” or a meritocracy.
by Saumil on December 17th, 2012 at 09:13
Woha , A miracle medicine is one which is of same price as it was last year, and look at generics medicine they are cheaper then what they were last year!!!!